OptiCept Technologies (OPTI) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
29 Aug, 2025Executive summary
Strong order intake in Q2 2025, especially in the olive oil segment, with SEK 27 million across 12 deals; many orders to be recognized as revenue in future quarters.
Commercial breakthroughs in olive oil and juice industries, with strategic partnerships and validation projects accelerating market entry.
Focus on reducing manufacturing costs and launching higher-capacity machines to strengthen market position.
Expansion of customer dialogues, particularly in olive oil (over 150 ongoing for next season), and new collaborations in juice and solid foods.
Financial highlights
Net sales for Q2 2025 were SEK 1.2 million, down from SEK 4.8 million in Q2 2024; total revenue SEK 3.2 million (Q2 2024: SEK 12.6 million).
Operating income for Q2 2025 was SEK -18.6 million (Q2 2024: SEK -9.7 million); net result SEK -19.1 million (Q2 2024: SEK -10.2 million).
EBITDA for Q2 2025 was SEK -16.0 million (Q2 2024: SEK -6.3 million).
Cash flow from operating activities improved to SEK -9.7 million (Q2 2024: SEK -12.1 million); total cash flow for the period was SEK 5.2 million (Q2 2024: SEK -7.8 million).
Cash and cash equivalents at period end were SEK 12.0 million.
Outlook and guidance
Cautious optimism for achieving positive EBITDA in upcoming quarters due to strong order intake and cost reductions.
Continued focus on commercial expansion, especially in olive oil and juice segments, with expectations of further orders as validation projects progress.
Ongoing efforts to secure additional liquidity and working capital to support expansion plans.
Latest events from OptiCept Technologies
- Record Q2 sales and orders, narrowed losses, and major new contracts drive global expansion.OPTI
Q2 2024 - FPS deal secures SEK 150M revenue; cost cuts and financing conversions support H2 2026 profitability.OPTI
Q1 2026 - Global licensing deal with FPS secures future revenues and enables a shift to innovation-led growth.OPTI
Q4 2025 - Yield-boosting tech and new partnerships fuel growth and positive EBITDA prospects for 2026.OPTI
DNB Carnegie Småbolagsdag - Positive EBITDA achieved in Q3 2025, with strong sales and improved margins year-over-year.OPTI
Q3 2025 - Revenue up, losses down, and new funding to accelerate global commercialization.OPTI
Q3 2024 - Strong Q1 growth, breakthrough orders, and new financing position OptiCept for expansion.OPTI
Q1 2025 - Revenue growth, improved margins, and new partnerships drive optimism for 2025.OPTI
Q4 2024